Research and Markets: US Diabetes Market Analysis

DUBLIN--()--Research and Markets ( has announced the addition of the "US Diabetes Market Analysis" report to their offering.

The epidemic of type-2 diabetes and its warning sign, pre-diabetes, is sweeping across the United States. It has been estimated that around 52% of the adult population will have diabetes or pre-diabetes by 2020. Yet shockingly, the vast majority more than 90% of people with prediabetes, and about a quarter of people with diabetes, are unaware of their conditions.

It is believed that this will have major implications for peoples health and life expectancy. It will result in out-of-control U.S. healthcare costs, placing growing strain on the budgets of families, employers, states, and the federal government. Our study indicates that health spending associated with diabetes and pre-diabetes was about US$ 194 Billion in 2010 (approximately 7% of total U.S. health spending).

The diabetes treatment market in the US comprises three related but distinct submarkets that address different aspects of the condition. Products in the US market are currently comprised of blood glucose monitors, lancets & test strips, continuous blood glucose monitors, insulin, insulin pumps, syringes, and other insulin delivery devices & anti-diabetic drugs. The most significant growth in this market (U.S.) is in continuous blood glucose meters, insulin pumps, and anti-diabetic drugs.

Our report US Diabetes Market Analysis, highlights the US diabetes market by segmenting it into oral diabetic drug market, insulin market, insulin delivery devices, and glucose monitoring market. Each of these segments have been thoroughly studied and analyzed in the report. Moreover, the report provides an overview of the patient profile and cost implications of diabetes in the country, which will help clients in identifying the future demand scenario.

The report studies the current development process and its effects on various segments of the industry. The research contains exhaustive information regarding the market players, government initiatives, and patient profile that will help clients in formulating market strategies and assess opportunity areas in the US diabetes market.

The report also includes a section of future projection and demand analysis that presents a rough idea about the prospective market trends to facilitate clients comprehend the market progress in coming years.

Key Topics Covered:

  • 1. Analyst View
  • 2. Research Methodology
  • 3. Market Overview
  • 4. Patient Profile Analysis
  • 5. Cost Implications
  • 6. Diabetes Drugs Market
  • 7. Insulin Delivery Devices Market
  • 8. Glucose Monitoring Devices Market
  • 9. Government Initiatives
  • 10. Key Players

Companies Mentioned:

  • Pfizer
  • GlaxoSmithKline
  • Takeda
  • Merck
  • Novo Nordisk
  • Eli Lilly
  • Sanofi-Aventis
  • Medtronic
  • Roche
  • LifeScan
  • Bayer
  • Abbott Laboratories

For more information visit


Research and Markets
Laura Wood, Senior Manager,
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716


Research and Markets
Laura Wood, Senior Manager,
U.S. Fax: 646-607-1907
Fax (outside U.S.): +353-1-481-1716